170 research outputs found

    Use of Spatial Archetypes for Optimized Energy Performance

    Get PDF

    Coordination Specification for Distributed Optimal System Design Using the Chi Language

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/76202/1/AIAA-2002-5410-847.pd

    Coordination Specification of the Analytical Target Cascading Process using the Chi Language

    Get PDF
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/76587/1/AIAA-2002-5637-610.pd

    A COMPREHENSIVE METRIC FOR COMPARING TIME HISTORIES IN VALIDATION OF SIMULATION MODELS WITH EMPHASIS ON VEHICLE SAFETY APPLICATIONS

    Get PDF
    ABSTRACT Computer modeling and simulation are the cornerstones of product design and development in the automotive industry. Computer-aided engineering tools have improved to the extent that virtual testing may lead to significant reduction in prototype building and testing of vehicle designs. In order to make this a reality, we need to assess our confidence in the predictive capabilities of simulation models. As a first step in this direction, this paper deals with developing a metric to compare time histories that are outputs of simulation models to time histories from experimental tests with emphasis on vehicle safety applications. We focus on quantifying discrepancy between time histories as the latter constitute the predominant form of responses of interest in vehicle safety considerations. First we evaluate popular measures used to quantify discrepancy between time histories in fields such as statistics, computational mechanics, signal processing, and data mining. Then we propose a structured combination of some of these measures and define a comprehensive metric that encapsulates the important aspects of time history comparison. The new metric classifies error components associated with three physically meaningful characteristics (phase, magnitude and topology), and utilizes norms, cross-correlation measures and algorithms such as dynamic time warping to quantify discrepancies. Two case studies demonstrate that the proposed metric seems to be more consistent than existing metrics. It is also shown how the metric can be used in conjunction with ratings from subject matter experts to build regression-based val- * Corresponding author, Phone/Fax: (734) 615-8991/647-8403 idation models

    Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Most patients with ductal pancreatic adenocarcinoma are diagnosed with locally advanced (unresectable) or metastatic disease. The aim of this study was to evaluate the prognostic significance of DNA ploidy in relation with established clinical and laboratory variables in such patients.</p> <p>Methods</p> <p>Two hundred and twenty six patients were studied retrospectively. Twenty two potential prognostic variables (demographics, clinical parameters, biochemical markers, treatment modality) were examined.</p> <p>Results</p> <p>Mean survival time was 38.41 weeks (95% c.i.: 33.17–43.65), median survival 27.00 weeks (95% c.i.: 23.18–30.82). On multivariate analysis, 10 factors had an independent effect on survival: performance status, local extension of tumor, distant metastases, ploidy score, anemia under epoetin therapy, weight loss, pain, steatorrhoea, CEA, and palliative surgery and chemotherapy. Patients managed with palliative surgery and chemotherapy had 6.7 times lower probability of death in comparison with patients without any treatment. Patients with ploidy score > 3.6 had 5.0 times higher probability of death in comparison with patients with ploidy score < 2.2 and these with ploidy score 2.2–3.6 had 6.3 times higher probability of death in comparison with patients with ploidy score < 2.2.</p> <p>Conclusion</p> <p>According to the significance of the examined factor, survival was improved mainly by the combination of surgery and chemotherapy, and the presence of low DNA ploidy score.</p
    • …
    corecore